6505--Phenytoin SA Capsules (VA-25-00022318)
ID: 36E79725R0016Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/bf7de48b30244f6b8f4a57f2bd048c57/view
Timeline
    Description

    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) for the procurement of Phenytoin Sodium Extended 100MG Sustained Action Capsules, designated as solicitation number 36E79725R0016. This unrestricted contract aims to ensure a reliable supply of these essential medications for the VA, Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS), with one contract awarded for an initial period of one year and the option for four additional one-year periods. The estimated annual requirement is approximately 16,653 units, highlighting the critical need for uninterrupted supply to support service members and associated organizations. Interested offerors should submit their proposals by March 7, 2025, following the electronic issuance of the RFP on or about February 21, 2025, and may direct inquiries to Contract Specialist Youlanda Duggar at youlanda.duggar@va.gov.

    Point(s) of Contact
    Contract SpecialistYoulanda Duggar
    (708) 786-4943
    youlanda.duggar@va.gov
    Files
    Title
    Posted
    36E79725R0016_1.docx
    The Department of Veterans Affairs (VA) intends to issue Request for Proposal (RFP) 36E79725R0016 for the procurement of Phenytoin Sodium Extended 100MG Sustained Action Capsules. This unrestricted contract will supply the VA, Department of Defense, Bureau of Prisons, and Indian Health Service with these medications. One contract will be awarded for a period of one year, with the possibility of four additional one-year option periods. The RFP is planned to be issued electronically around February 21, 2025, with responses due by March 7, 2025. The primary expectation from interested offerors includes providing an uninterrupted source of supply and having a unique NDC or UPC number for the drug. No physical copies of the solicitation will be available, and communications should be directed to the contracting office via email. The estimated annual usage for Phenytoin Capsules is detailed, indicating a total of approximately 16,653 units needed annually. Interested parties are encouraged to regularly check the provided URL for updates and amendments. This presolicitation notice illustrates the VA's commitment to ensuring a reliable supply of crucial medications for its service members and associated organizations.
    Lifecycle
    Title
    Type
    6505--Phenytoin SA Capsules (VA-25-00022318)
    Currently viewing
    Presolicitation
    Similar Opportunities
    6505--Bevacizumab Injection
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to procure Bevacizumab Injections through a Request for Proposal (RFP) designated as 36E79725R0019. This procurement aims to secure an uninterrupted supply of Bevacizumab, a critical pharmaceutical product used in the treatment of various medical conditions, for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The contract will span one year with four additional one-year option periods, and the estimated annual requirements include various package sizes of Bevacizumab, with a total estimated usage of over 100,000 vials. Interested offerors must submit their proposals by March 4, 2025, at 2:30 PM Central Time, and can direct inquiries to Contract Specialist Matthew Poulin at Matthew.Poulin@va.gov or by phone at 708-786-5186.
    6505--Carbidopa/Levodopa SA Tablet
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking pharmaceutical suppliers to establish a national contract for the provision of Carbidopa/Levodopa SA tablets through its Pharmaceutical Prime Vendor program. The Request for Proposal (RFP) outlines specific requirements for potential contractors, including pricing structures for the base year and four option years, compliance with the Drug Supply Chain Security Act, and the necessity for Good Manufacturing Practices (cGMP) status. This procurement is crucial for ensuring a reliable supply of essential medications for veteran and military healthcare systems across the nation. Interested parties should contact Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov for further details regarding the proposal submission process and deadlines.
    6505--Tamsulosin Capsules
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Tamsulosin Hydrochloride capsules as part of its Pharmaceutical Prime Vendor (PPV) Programs. Offerors are required to submit pricing for a base year and four option years, ensuring compliance with FDA standards and providing a unique 11-digit National Drug Code (NDC) for each product. This procurement is vital for maintaining a consistent supply of necessary pharmaceuticals to federal healthcare facilities, adhering to regulatory standards while ensuring availability and pricing stability. Interested parties must submit their offers by February 24, 2025, at 2:30 PM CST, and can contact Contract Specialist Andrew J. Cazares at Andrew.Cazares@va.gov for further information.
    6505--Rituximab and Biosimilars
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) designated as 36E79725R0021 for the procurement of Rituximab and its biosimilars, aimed at ensuring a reliable supply for various federal entities, including the Department of Defense and the Bureau of Prisons. The contract will span one year with four additional one-year options, emphasizing the necessity of maintaining an uninterrupted supply chain for these critical medications. Offerors must provide the exact product names along with unique National Drug Codes (NDC), with estimated annual requirements of 17,858 vials of Rituximab 10mg/ml and 25,111 vials of the 50mg/ml variant. The solicitation is expected to be published around February 17, 2025, with a closing date around March 4, 2025; interested parties should direct inquiries to Deb Fassl at Deborah.Fassl@va.gov.
    6505--Fluticasone Propionate 50 MCG/Spray Soln, Nasal, 16GM
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Fluticasone Propionate 50 MCG/Spray solution, nasal, 16GM, intended for use by various federal agencies including the Department of Defense, Bureau of Prisons, and Indian Health Service. The objective of this procurement is to secure a reliable and uninterrupted supply of this medication for a contract period of one year, with the possibility of four additional one-year extensions. This medication is crucial for treating nasal conditions, and the estimated annual requirement is approximately 5,784,828 bottles. The solicitation will be available electronically on or around February 11, 2025, with a closing date set for February 25, 2025. Interested vendors should direct inquiries to Michael Olszewski at michael.olszewski@va.gov or call 708-786-4966.
    6505--Baclofen Tablets (VA-25-00026620)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the supply of Baclofen Tablets under the solicitation titled "6505--Baclofen Tablets (VA-25-00026620)." The primary objective of this procurement is to establish a reliable source for various strengths of Baclofen tablets, ensuring consistent availability and quality at pre-negotiated prices, while complying with the Drug Supply Chain Security Act and Good Manufacturing Practices. This contract is crucial for maintaining the pharmaceutical needs of VA facilities, addressing issues such as compliance, backorders, and recalls. Interested offerors must submit their proposals by February 5, 2025, at 2:30 PM CST, and can direct inquiries to Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    Lansoprazole Capsules
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Lansoprazole capsules, specifically 30MG in 100 count bottles. This procurement aims to establish a national supply source for the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons, ensuring a reliable supply of this essential pharmaceutical item. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options, with the solicitation expected to be posted in April 2024. Interested parties should direct inquiries to Jeremy Brown at jeremy.brown@dla.mil or 215-737-6031, and are encouraged to set up automated notifications for updates on the solicitation through the DLA Bid Board System and Sam.Gov.
    Dimethyl Fumarate DR Presolicitation
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Dimethyl Fumarate DR capsules, specifically 120MG capsules in 14 count bottles and 240MG capsules in 60 count bottles. This procurement aims to establish a reliable national supply source for these pharmaceutical products, which are essential for Department of Defense (DoD) customers through the DLA prime vendor program. The contract will be a firm-fixed price, requirements type contract with a one-year base period and four one-year options, emphasizing compliance with federal regulations and efficient distribution of pharmaceuticals for military healthcare. Interested parties should contact Kevin Rafferty at kevin.rafferty@dla.mil or 215-737-0907 for further inquiries, and the projected solicitation date is February 2021, with an amendment extending the offer submission deadline to October 14, 2021, at 3:00 PM EST.
    6505--770-25-1-801-0073 - National CMOP D0286 DORZOLAMIDE -(VA-25-00021409) (VA-25-00021409)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of dorzolamide hydrochloride ophthalmic solution under the National Consolidated Mail Outpatient Pharmacy (CMOP) program. The primary objective is to acquire this pharmaceutical product in various quantities, ensuring compliance with specific contract terms, delivery standards, and regulatory requirements, including adherence to the Drug Supply Chain Security Act (DSCSA). This procurement is crucial for maintaining the quality and availability of essential medications for veterans' healthcare needs. Interested vendors must submit their quotes by January 30, 2025, at 3:00 PM Central Time, and can contact Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov for further information.
    6505--Domestic Pharmaceuticals/Med/Surge
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is conducting a Sources Sought notice to identify qualified domestic pharmaceutical manufacturers capable of supplying a range of medications for the Consolidated Mail Outpatient Pharmacy (CMOP). The procurement aims to ensure a reliable supply of domestically manufactured pharmaceuticals, including glucose test strips, hypertension treatments, and various other essential medications. This initiative is crucial for maintaining the health and well-being of veterans, as it supports ongoing healthcare needs. Interested manufacturers must submit their capability statements by February 5, 2025, to Josie Linaweaver at josie.linaweaver@va.gov, and are reminded to register in the System for Award Management (SAM) prior to contract award.